CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Total revenue	$ 1,481	$ 1,014
Operating expenses
Research and development	9,529	6,826
General and administrative	6,453	6,404
Total operating expenses	15,982	13,230
Loss from operations	(14,501)	(12,216)
Interest (expense) income, net	(914)	302
Other income (expense), net	65	(10)
Net loss	(15,350)	(11,924)
Other comprehensive income (loss)
Foreign currency translation adjustment	(8)	5
Comprehensive loss	(15,358)	(11,919)
Common Stock
Other comprehensive income (loss)
Net loss attributable to shareholders - basic	(15,350)	(11,899)
Net loss attributable to shareholders - diluted	$ (15,350)	$ (11,899)
Weighted shares used in calculating net loss per common share - basic (in shares)	291,996,562	257,232,636
Weighted shares used in calculating net loss per common share - diluted (in shares)	291,996,562	257,232,636
Net loss per share attributable to shareholders - basic (in USD per share)	$ (0.05)	$ (0.05)
Net loss per share attributable to shareholders - diluted (in USD per share)	$ (0.05)	$ (0.05)
Series B Convertible Preferred Stock
Other comprehensive income (loss)
Net loss attributable to shareholders - basic	$ 0	$ (25)
Net loss attributable to shareholders - diluted	$ 0	$ (25)
Weighted shares used in calculating net loss per common share - basic (in shares)	0	54,745
Weighted shares used in calculating net loss per common share - diluted (in shares)	0	54,745
Net loss per share attributable to shareholders - basic (in USD per share)	$ 0	$ (0.46)
Net loss per share attributable to shareholders - diluted (in USD per share)	$ 0	$ (0.46)
Collaborative Arrangements
Total revenue	$ 1,481	$ 1,014
Operating expenses
Research and development	$ 800	$ 100